Tech Company Financing Transactions
Unchained Labs Funding Round
Canaan Partners, Novo Ventures and TPG Biotech participated in a $25 million Series B funding round for Unchained Labs. The financing was announced on 3/2/2016.
Transaction Overview
Company Name
Announced On
3/2/2016
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series B
Investors
Proceeds Purpose
Unchained Labs announced its acquisition of Freeslate Inc., the leading provider of high-throughput solutions for biologics formulation development and small molecule chemistry.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
6870 Koll Center Pkwy.
Pleasanton, CA 94566
USA
Pleasanton, CA 94566
USA
Phone
Website
Email Address
Overview
We're building the next cool life sciences tools company. One that matters. One without old-school rules. One with products that'll make a real difference in the research scientists do every day. Our Optim products are just the first in a long line of more to come, so stay tuned!
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tim Harkness
Chief Operating Officer
Jason Novi
VP - Bus. Development
Will Lachnit
VP - Marketing
Taegen Clary
VP - Product Management
Krista Witte
Browse more venture capital transactions:
Prev: 3/2/2016: YPrime venture capital transaction
Next: 3/2/2016: Pathmatics venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. All VC database entries reported here are derived from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs